Literature DB >> 26705318

Mitotic Activity in Glioblastoma Correlates with Estimated Extravascular Extracellular Space Derived from Dynamic Contrast-Enhanced MR Imaging.

S J Mills1, D du Plessis2, P Pal2, G Thompson3, G Buonacorrsi4, C Soh5, G J M Parker4, A Jackson3.   

Abstract

BACKGROUND AND
PURPOSE: A number of parameters derived from dynamic contrast-enhanced MR imaging and separate histologic features have been identified as potential prognosticators in high-grade glioma. This study evaluated the relationships between dynamic contrast-enhanced MRI-derived parameters and histologic features in glioblastoma multiforme.
MATERIALS AND METHODS: Twenty-eight patients with newly presenting glioblastoma multiforme underwent preoperative imaging (conventional imaging and T1 dynamic contrast-enhanced MRI). Parametric maps of the initial area under the contrast agent concentration curve, contrast transfer coefficient, estimate of volume of the extravascular extracellular space, and estimate of blood plasma volume were generated, and the enhancing fraction was calculated. Surgical specimens were used to assess subtype and were graded (World Health Organization classification system) and were assessed for necrosis, cell density, cellular atypia, mitotic activity, and overall vascularity scores. Quantitative assessment of endothelial surface area, vascular surface area, and a vascular profile count were made by using CD34 immunostaining. The relationships between MR imaging parameters and histopathologic features were examined.
RESULTS: High values of contrast transfer coefficient were associated with the presence of frank necrosis (P = .005). High values of the estimate of volume of the extravascular extracellular space were associated with a fibrillary histologic pattern (P < .01) and with increased mitotic activity (P < .05). No relationship was found between mitotic activity and histologic pattern, suggesting that the correlation between the estimate of volume of the extravascular extracellular space and mitotic activity was independent of the histologic pattern.
CONCLUSIONS: A correlation between the estimate of volume of the extravascular extracellular space and mitotic activity is reported. Further work is warranted to establish how dynamic contrast-enhanced MRI parameters relate to more quantitative histologic measurements, including markers of proliferation and measures of vascular endothelial growth factor expression.
© 2016 by American Journal of Neuroradiology.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26705318      PMCID: PMC4817231          DOI: 10.3174/ajnr.A4623

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  51 in total

Review 1.  Modeling tracer kinetics in dynamic Gd-DTPA MR imaging.

Authors:  P S Tofts
Journal:  J Magn Reson Imaging       Date:  1997 Jan-Feb       Impact factor: 4.813

Review 2.  Contact inhibition (of proliferation) redux.

Authors:  Andrea I McClatchey; Alpha S Yap
Journal:  Curr Opin Cell Biol       Date:  2012-07-24       Impact factor: 8.382

3.  Action of nuclear and cytoplasmic fractions of liver homogenate on liver growth in the chick embryo.

Authors:  G D Tumanishvili; N V Salamatina
Journal:  J Embryol Exp Morphol       Date:  1968-08

4.  Prognostic significance of microvessel density determined by an anti-CD105/endoglin monoclonal antibody in astrocytic tumors: comparison with an anti-CD31 monoclonal antibody.

Authors:  Yongxue Yao; Toshihiko Kubota; Hiroaki Takeuchi; Kazufumi Sato
Journal:  Neuropathology       Date:  2005-09       Impact factor: 1.906

5.  Correlation of microvascular permeability derived from dynamic contrast-enhanced MR imaging with histologic grade and tumor labeling index: a study in human brain tumors.

Authors:  H C Roberts; T P Roberts; A W Bollen; S Ley; R C Brasch; W P Dillon
Journal:  Acad Radiol       Date:  2001-05       Impact factor: 3.173

6.  Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: confounding effect of elevated rCBV of oligodendrogliomas [corrected].

Authors:  Michael H Lev; Yelda Ozsunar; John W Henson; Amjad A Rasheed; Glenn D Barest; Griffith R Harsh; Markus M Fitzek; E Antonio Chiocca; James D Rabinov; Andrew N Csavoy; Bruce R Rosen; Fred H Hochberg; Pamela W Schaefer; R Gilberto Gonzalez
Journal:  AJNR Am J Neuroradiol       Date:  2004-02       Impact factor: 3.825

7.  Apparent diffusion coefficient and cerebral blood volume in brain gliomas: relation to tumor cell density and tumor microvessel density based on stereotactic biopsies.

Authors:  N Sadeghi; N D'Haene; C Decaestecker; M Levivier; T Metens; C Maris; D Wikler; D Baleriaux; I Salmon; S Goldman
Journal:  AJNR Am J Neuroradiol       Date:  2007-12-13       Impact factor: 3.825

8.  Hypoxia-regulated protein expression, patient characteristics, and preoperative imaging as predictors of survival in adults with glioblastoma multiforme.

Authors:  Jeannette R Flynn; Libo Wang; David L Gillespie; Gregory J Stoddard; Jason K Reid; Jason Owens; Grant B Ellsworth; Karen L Salzman; Anita Y Kinney; Randy L Jensen
Journal:  Cancer       Date:  2008-09-01       Impact factor: 6.860

Review 9.  DCE-MRI biomarkers in the clinical evaluation of antiangiogenic and vascular disrupting agents.

Authors:  J P B O'Connor; A Jackson; G J M Parker; G C Jayson
Journal:  Br J Cancer       Date:  2007-01-09       Impact factor: 7.640

10.  Glioma grading by microvascular permeability parameters derived from dynamic contrast-enhanced MRI and intratumoral susceptibility signal on susceptibility weighted imaging.

Authors:  Xiaoguang Li; Yongshan Zhu; Houyi Kang; Yulong Zhang; Huaping Liang; Sumei Wang; Weiguo Zhang
Journal:  Cancer Imaging       Date:  2015-03-21       Impact factor: 3.909

View more
  10 in total

1.  Application of Distributed Parameter Model to Assessment of Glioma IDH Mutation Status by Dynamic Contrast-Enhanced Magnetic Resonance Imaging.

Authors:  Zongfang Li; Wei Zhao; Bo He; Tong San Koh; Yanxi Li; Yizhen Zeng; Zhuo Zhang; Jingzhong Zhang; Zujun Hou
Journal:  Contrast Media Mol Imaging       Date:  2020-11-22       Impact factor: 3.161

2.  Assessment of quantitative dynamic contrast-enhanced MRI in distinguishing different histologic grades of breast phyllode tumor.

Authors:  Zhilong Yi; Mingwei Xie; Guangzi Shi; Ziliang Cheng; Hong Zeng; Ningyi Jiang; Zhuo Wu
Journal:  Eur Radiol       Date:  2021-09-07       Impact factor: 7.034

3.  Correlation between dynamic susceptibility contrast perfusion MRI and genomic alterations in glioblastoma.

Authors:  Kerem Ozturk; Esra Soylu; Zuzan Cayci
Journal:  Neuroradiology       Date:  2021-03-18       Impact factor: 2.804

4.  Prognostic value of preoperative dynamic contrast-enhanced MRI perfusion parameters for high-grade glioma patients.

Authors:  Agne Ulyte; Vasileios K Katsaros; Evangelia Liouta; Georgios Stranjalis; Christos Boskos; Nickolas Papanikolaou; Jurgita Usinskiene; Sotirios Bisdas
Journal:  Neuroradiology       Date:  2016-10-29       Impact factor: 2.804

Review 5.  Physiological Imaging Methods for Evaluating Response to Immunotherapies in Glioblastomas.

Authors:  Sanjeev Chawla; Vanessa Shehu; Pradeep K Gupta; Kavindra Nath; Harish Poptani
Journal:  Int J Mol Sci       Date:  2021-04-08       Impact factor: 5.923

6.  Correlation between amide proton transfer-related signal intensity and diffusion and perfusion magnetic resonance imaging parameters in high-grade glioma.

Authors:  Masanori Nakajo; Manisha Bohara; Kiyohisa Kamimura; Nayuta Higa; Takashi Yoshiura
Journal:  Sci Rep       Date:  2021-05-27       Impact factor: 4.379

7.  Specific Preoperative Dynamic Contrast-Enhanced MRI Semi-quantitative Markers Can Correlate With Vascularity in Specific Areas of Glioblastoma Tissue and Predict Recurrence.

Authors:  Mohammed A Azab; Sherief Ghozy; Sherif F Hassanein; Ahmed Y Azzam
Journal:  Cureus       Date:  2021-06-08

Review 8.  MRI in Glioma Immunotherapy: Evidence, Pitfalls, and Perspectives.

Authors:  Domenico Aquino; Andrea Gioppo; Gaetano Finocchiaro; Maria Grazia Bruzzone; Valeria Cuccarini
Journal:  J Immunol Res       Date:  2017-04-20       Impact factor: 4.818

Review 9.  Radiotherapy of Glioblastoma 15 Years after the Landmark Stupp's Trial: More Controversies than Standards?

Authors:  Tomas Kazda; Adam Dziacky; Petr Burkon; Petr Pospisil; Marek Slavik; Zdenek Rehak; Radim Jancalek; Pavel Slampa; Ondrej Slaby; Radek Lakomy
Journal:  Radiol Oncol       Date:  2018-06-06       Impact factor: 4.214

10.  Detection of early changes in the post-radiosurgery vestibular schwannoma microenvironment using multinuclear MRI.

Authors:  Daniel Lewis; Damien J McHugh; Ka-Loh Li; Xiaoping Zhu; Catherine Mcbain; Simon K Lloyd; Alan Jackson; Omar N Pathmanaban; Andrew T King; David J Coope
Journal:  Sci Rep       Date:  2021-08-03       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.